S Rauer
Overview
Explore the profile of S Rauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Volk T, Urbach H, Fingerle V, Bardutzky J, Rauer S, Dersch R
Sci Rep
. 2024 May;
14(1):12486.
PMID: 38816506
Affections of the central nervous system (CNS) rarely occur in Lyme neuroborreliosis (LNB). CNS manifestations can have residual neurological symptoms despite antibiotic treatment. We explored the spectrum of CNS affections...
2.
Dersch R, Sophocleous A, Cadar D, Emmerich P, Schmidt-Chanasit J, Rauer S
BMC Neurol
. 2021 Dec;
21(1):495.
PMID: 34937553
Background: Toscana virus (TOSV) is an arthropod-borne virus transmitted by phlebotomine sandflies (Phlebotomus sp.) widespread throughout the Mediterranean having the potential to cause meningoencephalitis in humans. In Germany, the vectors...
3.
Dersch R, Benkler D, Robinson T, Baumgartner A, Rauer S, Stich O
Fluids Barriers CNS
. 2018 Nov;
15(1):31.
PMID: 30392467
Background: Cerebrospinal fluid (CSF) analysis is a crucial method in the diagnostic process for suspected subarachnoid hemorrhage (SAH), especially when cerebral imaging is negative or inconclusive. CSF cytology (detection of...
4.
Dersch R, Sarnes A, Maul M, Minakowski O, Hottenrott T, Stich O, et al.
Ticks Tick Borne Dis
. 2018 Oct;
10(1):166-169.
PMID: 30352738
About 5-20% of the general population in endemic areas have seroprevalence for anti-borrelial antibodies. Previous studies have shown a high rate of 25-97% of persisting anti-borrelial antibodies in patients with...
5.
Dersch R, Rauer S
Nervenarzt
. 2017 Feb;
88(4):419-431.
PMID: 28175945
Lyme neuroborreliosis is a tick-borne infectious disease caused by the spirochete bacterium Borrelia burgdorferi sensu lato. Clinical manifestations are classified as early and late Lyme neuroborreliosis. Early manifestations are much...
6.
Spreer A, Rauer S, Wilking H, Fingerle V
Nervenarzt
. 2016 Nov;
87(12):1288-1292.
PMID: 27847963
Lyme borreliosis is the most frequent tick-borne infection in Europe. It is a multisystemic disease affecting the skin, joints, heart, in rare cases the eyes and regularly the nervous system....
7.
Stich O, Perera S, Berger B, Jarius S, Wildemann B, Baumgartner A, et al.
J Neurol Sci
. 2016 Apr;
364:29-32.
PMID: 27084211
Introduction: Antibodies against neurofascin, an axo-glial protein located around the node of Ranvier, have been shown to contribute to axonal pathology both in vitro and in experimental autoimmune encephalomyelitis models....
8.
Dersch R, Toews I, Sommer H, Rauer S, Meerpohl J
BMC Neurol
. 2015 Nov;
15:242.
PMID: 26607686
Background: Many aspects of clinical management of Lyme neuroborreliosis are subject to intense debates. Guidelines show considerable variability in their recommendations, leading to divergent treatment regimes. The most pronounced differences...
9.
Dersch R, Sommer H, Rauer S, Meerpohl J
J Neurol
. 2015 Oct;
263(1):17-24.
PMID: 26459093
Controversy exists about residual symptoms after pharmacological treatment of Lyme neuroborreliosis. Reports of disabling long-term sequels lead to concerns in patients and health care providers. We systematically reviewed the available...
10.
Ziemssen T, Rauer S, Stadelmann C, Henze T, Koehler J, Penner I, et al.
PLoS One
. 2015 Sep;
10(9):e0138243.
PMID: 26393519
Background: So far, clinical studies in primary progressive MS (PPMS) have failed to meet their primary efficacy endpoints. To some extent this might be attributable to the choice of assessments...